Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by Crossref.
Lancaster, J. L.
Mortimore, S.
McCormick, M.
and
Hart, C. A.
1999.
Systemic absorption of gentamicin in the management of active mucosal chronic otitis media.
Clinical Otolaryngology and Allied Sciences,
Vol. 24,
Issue. 5,
p.
435.
Lancaster, J. L.
Makura, Z. G. G.
Porter, G.
and
McCormick, M.
1999.
Topical aminoglycosides in the management of active mucosal chronic suppurative otitis media.
The Journal of Laryngology & Otology,
Vol. 113,
Issue. 1,
p.
10.
Weber, Peter C.
Roland, Peter S.
Hannley, Maureen
Friedman, Rick
Manolidis, Spiros
Matz, Greg
Owens, Fred
Rybak, Leonard
and
Stewart, Michael G.
2004.
The Development of Antibiotic Resistant Organisms with the Use of Ototopical Medications.
Otolaryngology–Head and Neck Surgery,
Vol. 130,
Issue. S3,
Tang, Raymond Kai Tat
and
Tse, Raymond Kwok-Kay
2011.
Acute Renal Failure After Topical Fortified Gentamicin and Vancomycin Eyedrops.
Journal of Ocular Pharmacology and Therapeutics,
Vol. 27,
Issue. 4,
p.
411.
Wiesner, Lisa
Prause, Maarten
and
Lovsin Barle, Ester
2018.
Topical otic drugs in a multi-purpose manufacturing facility: a guide on determination and application of permitted daily exposure (PDE).
Pharmaceutical Development and Technology,
Vol. 23,
Issue. 3,
p.
261.